An updated systematic review and meta-analysis of 53 randomized clinical trials revealed significant effects on reducing fasting blood glucose, HOMA-IR (homeostasis model assessment of insulin resistance), and serum insulin levels, while increasing QUICKI (quantitative insulin sensitivity check index). This evidence concerns the gene INS and Insulin resistance.